Membranoproliferative Glomerulonephritis
What's New
Last Posted: Jan 29, 2024
- Anti-factor B antibodies in atypical hemolytic uremic syndrome.
Priyanka Khandelwal, et al. Pediatric nephrology (Berlin, Germany) 2024 0 - Low C3 in a 4-month-old baby: is it a problem?
Gül?ah Kaya Aksoy, et al. Pediatric nephrology (Berlin, Germany) 2023 0 - Genetic investigation of Nordic patients with complement-mediated kidney diseases.
Viktor Rydberg, et al. Frontiers in immunology 2023 0 1254759 - The Association of Class I and II Human Leukocyte Antigen Serotypes With End-Stage Kidney Disease Due to Membranoproliferative Glomerulonephritis and Dense Deposit Disease.
Halimat Afolabi, et al. American journal of kidney diseases : the official journal of the National Kidney Foundation 2023 0 - Rare Variants in Complement Gene in C3 Glomerulopathy and Immunoglobulin-Mediated Membranoproliferative Glomerulonephritis.
Marie Sophie Meuleman, et al. Clinical journal of the American Society of Nephrology : CJASN 2023 0 - Outcome of membranoproliferative glomerulonephritis and C3-glomerulopathy in children and adolescents.
Holle Johannes, et al. Pediatric nephrology (Berlin, Germany) 2018 0 (12) 2289-2298 - Lack of Evidence for an Association between Previous HEV Genotype-3 Exposure and Glomerulonephritis in General.
Pischke Sven, et al. Pathogens (Basel, Switzerland) 2022 0 (1) - Prospects of genetic testing for steroid-resistant nephrotic syndrome in Nigerian children: a narrative review of challenges and opportunities.
Anigilaje Emmanuel Ademola et al. International journal of nephrology and renovascular disease 2019 12119-136 - The role of MEFV mutations in the concurrent disorders observed in patients with familial Mediterranean fever.
Güncan Sabri, et al. European journal of rheumatology 2016 9 (3) 118-121 - Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome.
Iatropoulos Paraskevas, et al. Molecular immunology 2016 2 131-142 - C3 glomerulonephritis and autoimmune disease: more than a fortuitous association?
Alexander Mariam P, et al. Journal of nephrology 2015 7 - Paraoxonase 1 polymorphisms in patients with primary glomerulonephritis: a single-center study in Turkey.
Eren Zehra, et al. Iranian journal of kidney diseases 2012 5 (3) 181-5 - Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies.
Servais A, et al. Kidney international 2012 3 - Membranoproliferative glomerulonephritis
From NCATS Genetic and Rare Diseases Information Center - Complement factor H polymorphisms, renal phenotypes and age-related macular degeneration: the Blue Mountains Eye Study.
Xing C, et al. Genes and immunity 2008 4 (3) 231-9 - Complement factor H polymorphism p.Tyr402His and cuticular Drusen.
Grassi Michael A, et al. Archives of ophthalmology (Chicago, Ill. : 1960) 2007 1 (1) 93-7 - Polymorphism of the FcgammaRIIalpha IgG receptor in patients with lupus nephritis and glomerulopathy.
Gelmetti Adriana Peixoto, et al. The Journal of rheumatology 2006 3 (3) 523-30 - Is paraoxonase 192 gene polymorphism a risk factor for membranoproliferative glomerulonephritis in children?
Bilge Ilmay, et al. Cell biochemistry and function 0 0 (2) 159-65 - Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease).
Abrera-Abeleda M A, et al. Journal of medical genetics 2006 7 (7) 582-9 - Two subtypes of hepatitis B virus-associated glomerulonephritis are associated with different HLA-DR2 alleles in Koreans.
Park M H, et al. Tissue antigens 2003 12 (6) 505-11
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:May 14, 2024
- Content source: